These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22113650)

  • 1. Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging.
    Makanyanga J; Punwani S; Taylor SA
    Abdom Imaging; 2012 Dec; 37(6):933-43. PubMed ID: 22113650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease.
    Maccioni F; Staltari I; Pino AR; Tiberti A
    Abdom Imaging; 2012 Dec; 37(6):944-57. PubMed ID: 22639331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease.
    Bernstein CN; Greenberg H; Boult I; Chubey S; Leblanc C; Ryner L
    Am J Gastroenterol; 2005 Nov; 100(11):2493-502. PubMed ID: 16279905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
    Maccioni F; Bruni A; Viscido A; Colaiacomo MC; Cocco A; Montesani C; Caprilli R; Marini M
    Radiology; 2006 Feb; 238(2):517-30. PubMed ID: 16371574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI in Crohn's disease: Current status and recommendations.
    Dohan A; Taylor S; Hoeffel C; Barret M; Allez M; Dautry R; Zappa M; Savoye-Collet C; Dray X; Boudiaf M; Reinhold C; Soyer P
    J Magn Reson Imaging; 2016 Dec; 44(6):1381-1396. PubMed ID: 27249184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging evaluation of the activity of Crohn's disease.
    Koh DM; Miao Y; Chinn RJ; Amin Z; Zeegen R; Westaby D; Healy JC
    AJR Am J Roentgenol; 2001 Dec; 177(6):1325-32. PubMed ID: 11717076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading luminal Crohn's disease: which MRI features are considered as important?
    Ziech ML; Bossuyt PM; Laghi A; Lauenstein TC; Taylor SA; Stoker J
    Eur J Radiol; 2012 Apr; 81(4):e467-72. PubMed ID: 21684703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced MR enterography as a stand-alone tool to evaluate Crohn's disease in a paediatric population.
    Spieler B; Hindman N; Levy J; Zabrieski K; Sahlein D; Seuss C; Kim S
    Clin Radiol; 2013 Oct; 68(10):1024-30. PubMed ID: 23796211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
    Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
    Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.
    Pupillo VA; Di Cesare E; Frieri G; Limbucci N; Tanga M; Masciocchi C
    Radiol Med; 2007 Sep; 112(6):798-809. PubMed ID: 17885739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydro-MRI in Crohn's disease: appraisal of disease activity.
    Schunk K; Kern A; Oberholzer K; Kalden P; Mayer I; Orth T; Wanitschke R
    Invest Radiol; 2000 Jul; 35(7):431-7. PubMed ID: 10901105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving role of MRI in Crohn's disease.
    Yacoub JH; Obara P; Oto A
    J Magn Reson Imaging; 2013 Jun; 37(6):1277-89. PubMed ID: 23712842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bowel wall enhancement in magnetic resonance colonography for assessing activity in Crohn's disease.
    Röttgen R; Herzog H; Lopez-Häninnen E; Felix R
    Clin Imaging; 2006; 30(1):27-31. PubMed ID: 16377481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI texture analysis parameters of contrast-enhanced T1-weighted images of Crohn's disease differ according to the presence or absence of histological markers of hypoxia and angiogenesis.
    Bhatnagar G; Makanyanga J; Ganeshan B; Groves A; Rodriguez-Justo M; Halligan S; Taylor SA
    Abdom Radiol (NY); 2016 Jul; 41(7):1261-9. PubMed ID: 26867730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of MR enterography and ultrasound for the investigation of small bowel Crohn's disease.
    Bhatnagar G; Von Stempel C; Halligan S; Taylor SA
    J Magn Reson Imaging; 2017 Jun; 45(6):1573-1588. PubMed ID: 27943484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the extension and the inflammatory activity in Crohn's disease: comparison of ultrasound and MRI.
    Martínez MJ; Ripollés T; Paredes JM; Blanc E; Martí-Bonmatí L
    Abdom Imaging; 2009; 34(2):141-8. PubMed ID: 18214582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MRI in chronic inflammatory bowel disease].
    Hansmann HJ; Hess T; Hahmann M; Erb G; Elsing C; Richter GM; Düx M
    Rofo; 2001 Jan; 173(1):4-11. PubMed ID: 11225416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers and MR imaging findings as predictors of crohn disease activity in patients scanned by contrast-enhanced MR enterography.
    Quaia E; Cabibbo B; Sozzi M; Gennari AG; Pontello M; Degrassi F; Cova MA
    Acad Radiol; 2014 Oct; 21(10):1225-32. PubMed ID: 24998692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations.
    Malagò R; Manfredi R; Benini L; D'Alpaos G; Mucelli RP
    Abdom Imaging; 2008; 33(6):669-75. PubMed ID: 18228087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.
    Rimola J; Rodriguez S; García-Bosch O; Ordás I; Ayala E; Aceituno M; Pellisé M; Ayuso C; Ricart E; Donoso L; Panés J
    Gut; 2009 Aug; 58(8):1113-20. PubMed ID: 19136510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.